Status:
COMPLETED
The Effect of Ganglion Sphenopalatine Block (GSP-block) Follow-Up
Lead Sponsor:
University Hospital Bispebjerg and Frederiksberg
Conditions:
Post-Dural Puncture Headache
Ganglion Sphenopalatine Block
Eligibility:
All Genders
Brief Summary
The purpose of this study is to evaluate the long term effects of the ganglion sphenopalatine block (GSP block) on postdural puncture headache.
Detailed Description
Adult patients with postdural puncture headache was enrolled in main study (NCT03652714). In the main study the patients was randomised to receive a ganglion sphenopalatine block (GSP-block) with eith...
Eligibility Criteria
Inclusion
- Patients who where included in main study and had the following eligibility criteria:
- Age \> 18 years
- Patients with postdural puncture headache defined as moderate to severe postural headache (VAS \>= 30mm) after lumbar puncture or accidental dural puncture during epidural insertion with an onset within 3 days following the puncture.
- Lack of headache remission within 1 day after dural puncture and after treatment with fluids, caffeine and paracetamol
- Patients who have given their written informed consent for participation in the study after fully understanding the protocol content and limitations.
Exclusion
- Patients who cannot cooperate to the study
- Patients who does not understand or speak Danish
- Allergy to the drugs used in the study
- Has taken opioids within 12 hours prior to intervention
Key Trial Info
Start Date :
November 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 19 2022
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05301387
Start Date
November 26 2021
End Date
April 19 2022
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg and Frederiksberg Hospital, University of Copenhagen
Copenhagen, Denmark, 2400